Zymeworks Inc. (ZYME)

Zymeworks Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	157.56	400.91	201.87	242.04	128.45
Short-Term Investments	216.77	91.32	50.74	184.32	170.45
Cash & Cash Equivalents	374.33	492.23	252.61	426.35	298.9
Cash Growth	-23.95%	94.86%	-40.75%	42.64%	49.33%
Receivables	19.48	33.4	15.61	15.29	2.19
Other Current Assets	19.12	19.07	20	13.43	10.74
Total Current Assets	412.93	544.71	288.22	455.08	311.83
Property, Plant & Equipment	37.54	47.65	49.77	17.61	16.5
Long-Term Investments	81.93	0.89	0.89	25.92	0
Goodwill and Intangibles	19.67	20.77	15.85	17.32	18.07
Other Long-Term Assets	28.81	34.71	34.4	22.45	21.8
Total Long-Term Assets	167.95	104.02	100.91	83.3	56.38
Total Assets	580.88	648.73	389.13	538.38	368.21
Accounts Payable	45.99	87.47	62.79	43.66	35.69
Deferred Revenue	36.64	32.94	32.94	32.94	32.94
Current Debt	4.26	3.32	1.31	2.71	1.28
Other Current Liabilities	-31.13	-28.11	-25.19	6.36	12.64
Total Current Liabilities	55.76	95.63	71.85	85.67	82.55
Long-Term Debt	22.37	24.67	30.92	5.81	5.6
Other Long-Term Liabilities	37.94	35.48	37.26	36.98	34.37
Total Long-Term Liabilities	60.31	60.14	68.19	42.79	39.97
Total Liabilities	116.07	155.77	140.04	128.45	122.52
Total Debt	26.63	27.99	32.23	8.52	6.88
Debt Growth	-4.86%	-13.17%	278.23%	23.85%	-
Retained Earnings	-677.44	-558.76	-683.1	-471.26	-290.71
Comprehensive Income	-6.6	-6.66	-6.66	-6.66	-6.66
Shareholders' Equity	464.81	492.96	249.09	409.92	245.68
Net Cash / Debt	347.7	464.24	220.38	417.83	292.02
Net Cash / Debt Growth	-25.10%	110.66%	-47.26%	43.08%	45.89%
Net Cash Per Share	5.05	7.11	4.23	8.29	7.68
Working Capital	357.16	449.08	216.37	369.41	229.28
Book Value Per Share	6.75	7.56	4.83	8.14	6.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).